This inventor holds 1 USPTO granted patent. Top assignee: Fuji Chemical Industries Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Teppei Shibata: Innovator in Porous Silica Particle Composition
Introduction
Teppei Shibata is a notable inventor based in Nakaniikawa-gun, Japan. He has made significant contributions to the field of pharmaceutical additives through his innovative work on porous silica particle compositions. His research focuses on enhancing the properties of silica used in various formulations.
Latest Patents
Teppei Shibata holds a patent for a porous silica particle composition. This composition is characterized by its superior fluidity, oil absorption ability, and compression moldability compared to conventional silica. The patent outlines specific properties, including a BET specific surface area ranging from 250 to 1,000 m/g, an average particle diameter between 1 to 150 μm, a pore volume from 0.1 to 8.0 cm/g, and an oil absorption capacity from 2.2 to 5.0 mL/g. These attributes make it suitable as an additive for pharmaceutical formulations.
Career Highlights
Shibata is associated with Fuji Chemical Industries Co., Ltd., where he has been instrumental in advancing the company's research and development efforts. His work has not only contributed to the company's portfolio but has also positioned it as a leader in the pharmaceutical additive market.
Collaborations
Teppei Shibata has collaborated with notable colleagues, including Koji Hoda and Hiroshi Kawaguchi. Their combined expertise has fostered a productive research environment, leading to innovative solutions in the field of pharmaceuticals.
Conclusion
Teppei Shibata's contributions to the development of porous silica particle compositions highlight his role as an influential inventor in the pharmaceutical industry. His innovative approach continues to pave the way for advancements in pharmaceutical additives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile